Category Archives: News

Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Convention as Part of a Collaboration with Phage Pharmaceuticals

Posted on June 12, 2012 by Roman Levytskyy

– Custom Protein Production Service Offered for Research Grade and cGMP Production  Using Proprietary Phage Expression System TUSTIN, CA, June 11, 2012 – Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will collaborate with … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

California FDB Grants Drug Manufacturing License to Phage Pharmaceuticals

Posted on March 30, 2012 by admin

San Diego, California – Phage Pharmaceuticals, Inc., a manufacturer of therapeutic proteins, has received a drug manufacturing license from the California Department of Public Health, Food and Drug Branch (CA FDB). Prior to issuing the license the FDB inspected the … Continue reading →

Posted in News | Tagged , , , | Leave a comment

Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations

Posted on December 20, 2011 by admin

San Diego, CA, December 20, 2011 – Phage Pharmaceuticals, a private biopharmaceutical company based in San Diego, California, announced today the submission of an IND to the US FDA to initiate a Phase 1 clinical trial of its FGF-1 drug … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent

Posted on November 6, 2011 by admin

San Diego, CA, November 6, 2011 – Stamford Bioprocess Technologies and Phage Pharmaceuticals recently signed a Letter of Intent to provide mutual access to the companies’ complementary technologies and expertise. While Stamford has extensive experience in the production of biologic … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech

Posted on October 10, 2011 by admin

Shanghai, People’s Republic of China, October 10, 2011 – Phage Pharmaceuticals announced plans at the BIO China International Conference to establish a joint venture to utilize Phage’s “Intelligent Protein” platform as well as to develop and market cosmeceuticals in China … Continue reading →

Posted in News | Tagged , , , , , | Leave a comment

Dr. Thomas Stegmann appointed as Chief Medical Officer for Phage Pharmaceuticals, Inc.

Posted on August 22, 2011 by admin

San Diego, CA, August 22, 2011 – Phage Pharmaceuticals named Thomas Stegmann, M.D., Ph.D., to the newly created position of Chief Medical Officer (CMO). “I am pleased to welcome such a highly regarded and respected physician and scientist as Dr. … Continue reading →

Posted in News | Leave a comment

Phage Pharmaceuticals Names Jamie Oliver to Serve as New CEO

Posted on June 27, 2011 by admin

San Diego, June 27, 2011 – Phage Pharmaceuticals announced that its Board of Directors has appointed Jamie Oliver, Pharm.D., to lead the company as CEO. Dr. Oliver also joined Phage’s Board of Directors. “We are fortunate to have been able … Continue reading →

Posted in News | Leave a comment

Phage Pharmaceuticals Receives Grant for Qualifying Therapeutic Discovery Project

Posted on November 3, 2010 by admin

SAN DIEGO, November 3, 2010 — Phage Pharmaceuticals, Inc., a private San Diego-based clinical-stage specialty biopharmaceutical developer and manufacturer of therapeutic proteins, announced today that it has been awarded a grant of $244,479.25 under the Qualifying Therapeutic Discovery Project Program. … Continue reading →

Posted in News | Leave a comment